High-dose gold nanoparticle treatment outperformed orlistat in reversing obesity-related damage in rats, according to ...

The kidney transplant rejection prophylaxis market is projected to experience steady growth, driven by the introduction of innovative therapi ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

EastEnders fans were left fuming during the show's 40th anniversary live episode after they spotted a glaring prop blunder - ...

Robinson, who has been battling renal kidney failure for years, remains in the hospital but is recovering well, his family said on Friday.

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

The team found that a DNA structure, called a guanine quadruplex ... Groundbreaking discovery at WMU medical school offers new hope for kidney disease patients The breakthrough began with a ...

While sparkling coffee is generally safe and healthy, some might want to skip this trend. The drink could make reflux ...

A study finds the byproduct of a chemical used to disinfect drinking water in thousands of Western Pennsylvania homes could ...

AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.